Effect of Nardostachys jatamansi DC. on Apoptosis, Inflammation and Oxidative Stress Induced by Doxorubicin in Wistar Rats

Plants
Mhaveer SinghSayeed Ahmad

Abstract

The study aimed to investigate the protective action of jatamansi (Nardostachys jatamansi DC.) against doxorubicin cardiotoxicity. Methanolic extract of jatamansi (MEJ) was prepared and standardized using HPTLC fingerprinting, GC-MS chemoprofiling, total phenolic content, and antioxidant activity in vitro. Further in vivo activity was evaluated using rodent model. Animals were divided into five groups (n = 6) namely control (CNT) (Normal saline), toxicant (TOX, without any treatment), MEJ at low dose (JAT1), MEJ at high dose (JAT2), and standard desferrioxamine (STD). All groups except control received doxorubicin 2.5 mg per Kg intra-peritoneally for 3 weeks in twice a week regimen. After 3 weeks, the blood samples and cardiac tissues were collected from all groups for biochemical and histopathological evaluation. Treatment with MEJ at both dose levels exhibited significant reduction (p < 0.001 vs. toxicant) of serum CK-MB (heart creatine kinase), LDH (Lactate dehydrogenase) & HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) levels, and tissue MDA (melondialdehyde) level; insignificant difference was observed (p > 0.05) in TNF-alpha (tumour necrosis factor), IL-6 (interleukine-6) levels and caspase activity as compared to TOX. H...Continue Reading

References

Mar 1, 1991·Journal of Molecular and Cellular Cardiology·A CalderoneJ L Rouleau
Jan 1, 1974·American Journal of Clinical Pathology·G Lum, S R Gambino
Sep 24, 1998·The New England Journal of Medicine·P K Singal, N Iliskovic
Apr 8, 2003·Current Medicinal Chemistry. Anti-cancer Agents·Riccardo Zucchi, Romano Danesi
Dec 20, 2003·Basic Research in Cardiology·Rainer SchulzGerd Heusch
Feb 21, 2004·Biochemical and Biophysical Research Communications·Teruhisa KawamuraToru Kita
May 11, 2005·Molecular Pharmacology·X XuD R Richardson
Aug 13, 2005·Journal of Ethnopharmacology·Vidya S RaoK Sudhakar Karanth
Feb 3, 2006·The Journal of Pharmacy and Pharmacology·Rajakannu SubashiniThiruvengadam Devaki
Apr 4, 2006·Journal of Medicinal Food·Hanumanthachar Joshi, Milind Parle
Feb 1, 1991·Planta medica·A BagchiH Hikino
Mar 3, 2007·Progress in Cardiovascular Diseases·Genzou Takemura, Hisayoshi Fujiwara
Jul 27, 2007·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Emilio ChiosiGennaro Illiano
Jan 5, 2008·American Journal of Physiology. Gastrointestinal and Liver Physiology·Guillermo L LehmannRaúl A Marinelli
May 11, 2010·International Journal of Cardiology·Himanshu SharmaUma Bhandari
Aug 28, 2010·Journal of Natural Medicines·Gi-Sang BaeSung-Joo Park
Apr 2, 2011·Indian Journal of Pharmacology·A H M ThippeswamyMahesh Patil
Dec 17, 2016·International Journal of Molecular Sciences·Maja GrabackaKrzysztof Reiss
Nov 30, 2018·Frontiers in Pharmacology·Canan G Nebigil, Laurent Désaubry
Oct 18, 2020·Complementary Therapies in Medicine·Muzafar Din Ahmad Bhat, Shah Agaz Malik

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
MDA

Software Mentioned

Graph pad Prism3

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.